---
title: "Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion"
ocid: "ocds-h6vhtk-04fb6d"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04fb6d"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-04fb6d.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-04fb6d.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "NHS BLOOD AND TRANSPLANT"
published: "2025-05-20"
---

# Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion

Buyer: NHS BLOOD AND TRANSPLANT  
Current stage: Planning  
OCID: ocds-h6vhtk-04fb6d

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04fb6d)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-04fb6d.json)

## Summary

NHS Blood and Transplant (NHSBT), a central government public authority based in Bristol, UK, is currently in the planning stage of a tender process involving the procurement of additive solutions for the washing and re-suspension of red blood cell components suitable for transfusion. The tender, titled "Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion," invites expressions of interest by 30th June 2025. This procurement exercise falls under the medical solutions industry category and is valued at approximately £240,000, although the total gross value is £288,000. This initiative is aimed at sourcing sterile solutions such as SAG-M or PAGGSM, and ensuring compliance with UK transfusion guidelines. The engagement process will help NHSBT assess market capabilities and supplier readiness, with the future possibility of formal tenders or contracts post-2026.

This tender represents a notable opportunity for businesses specialising in pharmaceutical products, blood substitutes, and infusion supplies, specifically those manufacturing red cell additive solutions. Innovative suppliers capable of providing sterile, well-labelled solutions that are compatible with NHSBT's specialised washing processes can leverage this engagement to showcase their capabilities and secure long-term government contracts. The engagement particularly suits small and medium-sized enterprises (SMEs) looking to expand their footprint in the healthcare sector by collaborating with a central public authority. Participants can benefit by aligning their product offerings with NHSBT’s specific requirements and potentially positioning themselves for further procurement opportunities leading up to and beyond the commencement date of 1st November 2026.

## Notice

NHS Blood and Transplant (NHSBT) invites expressions of interest from potential suppliers (of an existing product) or manufacturers capable of manufacturing any approved red cell storage solution, for example (but not limited to) SAG-M (Saline-Adenine-Glucose-Mannitol) or PAGGSM (Phosphate-Adenine-Glucose-Guanylate-Saline-Mannitol), for Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion. Washed components must meet the requirements of Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK, section 7.3.3. which can be found here: https://www.transfusionguidelines.org/red-book/chapter-7/7-3/7-3-3 This engagement aims to assess market capability, capacity, and interest in supplying a sterile, labelled product. Requirement Interested parties must be able to supply or manufacture additive solution bags that meet the following criteria: - Solution Type: SAG-M or PAGGSM or other approved red cell storage solution - Sterility: Bags must be sterile and suitable for clinical use - Design: Each bag must include a pigtail for sterile docking - Labeling: Bags must be clearly and accurately labelled in accordance with applicable regulatory standards - Compatibility: The solution must be suitable for use in NHSBTs red blood cell washing processes Supplier Engagement Objectives Through this engagement, NHSBT seeks to: - Understand the current market landscape and supplier capabilities - Identify potential suppliers for future procurement opportunities - Gather feedback on product availability, lead times, and regulatory compliance Next Steps Suppliers interested in participating in this market engagement are invited to express their interest by contacting samantha.rix@nhsbt.nhs.uk . Further information, including a questionnaire or Request for Information (RFI), may be issued following initial expressions of interest. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.

### Planning Information

NHS Blood and Transplant (NHSBT) invites expressions of interest from potential suppliers (of an existing product) or manufacturers capable of manufacturing any approved red cell storage solution, for example (but not limited to) SAG-M (Saline-Adenine-Glucose-Mannitol) or PAGGSM (Phosphate-Adenine-Glucose-Guanylate-Saline-Mannitol), for Additive Solution for the washing and re-suspension of Red Blood Cell components suitable for transfusion. Washed components must meet the requirements of Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK, section 7.3.3. which can be found here: https://www.transfusionguidelines.org/red-book/chapter-7/7-3/7-3-3 This engagement aims to assess market capability, capacity, and interest in supplying a sterile, labelled product. Requirement Interested parties must be able to supply or manufacture additive solution bags that meet the following criteria: - Solution Type: SAG-M or PAGGSM or other approved red cell storage solution - Sterility: Bags must be sterile and suitable for clinical use - Design: Each bag must include a pigtail for sterile docking - Labeling: Bags must be clearly and accurately labelled in accordance with applicable regulatory standards - Compatibility: The solution must be suitable for use in NHSBTs red blood cell washing processes Supplier Engagement Objectives Through this engagement, NHSBT seeks to: - Understand the current market landscape and supplier capabilities - Identify potential suppliers for future procurement opportunities - Gather feedback on product availability, lead times, and regulatory compliance Next Steps Suppliers interested in participating in this market engagement are invited to express their interest by contacting samantha.rix@nhsbt.nhs.uk . Further information, including a questionnaire or Request for Information (RFI), may be issued following initial expressions of interest. No business whatsoever is guaranteed under any resulting framework or contract, and there is no guarantee that any framework or contract will be put in place in relation to this notice. Each Potential Supplier is responsible for all costs and expenses incurred in relation to this Market Engagement exercise, each Potential Supplier accepts by its participation in this process, including without limitation the submission of any documents or attending meetings, that it will not be entitled to claim from NHSBT any costs, expenses or liabilities that it may incur irrespective of whether or not its tender is successful or if a tender or resulting framework or contract is withdrawn for any reason.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/022921-2025 |
| Notice type | UK2 - Preliminary Market Engagement Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | SME |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 20 May 2025 |
| Submission deadline | Not specified |
| Future notice date | 1 Apr 2026 |
| Award date | Not specified |
| Contract period | 1 Nov 2026 - 31 Oct 2028 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £240,000 |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planning |
| Lots status | Planning |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS BLOOD AND TRANSPLANT |
| Locality | BRISTOL |
| Post town | Bristol |
| Postcode | BS34 7QH |
| Country | England |
| ITL 1 | TLK South West (England) |
| ITL 2 | TLK5 West of England |
| ITL 3 | TLK52 Bath & North East Somerset and South Gloucestershire |
| Local authority | South Gloucestershire |
| Electoral ward | Filton |
| Westminster constituency | Filton and Bradley Stoke |
| Delivery location | Not specified |

## CPV Codes

### Divisions

- 24 - Chemical products
- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 24000000 - Chemical products
- 24950000 - Specialised chemical products
- 33141613 - Blood bags
- 33194220 - Blood-transfusion supplies
- 33600000 - Pharmaceutical products
- 33621400 - Blood substitutes and perfusion solutions
- 33692000 - Medical solutions

## Release History

- 20 May 2025 at 06:40 - PlanningUpdate - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/022921-2025
- 19 May 2025 at 07:49 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/022435-2025
- 19 May 2025 at 07:49 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/022434-2025
- 1 Apr 2025 at 13:48 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/012299-2025

## Documents

- https://www.find-tender.service.gov.uk/Notice/022921-2025
  20th May 2025 - Preliminary market engagement notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/022435-2025
  19th May 2025 - Preliminary market engagement notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/022434-2025
  19th May 2025 - Preliminary market engagement notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/012299-2025
  1st April 2025 - Preliminary market engagement notice on Find a Tender

## Notice URLs

- https://www.legislation.gov.uk/ukpga/2023/54/contents
- https://www.nhsbt.nhs.uk/
- https://www.transfusionguidelines.org/red-book/chapter-7/7-3/7-3-3

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-04fb6d. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-04fb6d.json.